- NZ$2.78bn
- NZ$4.46bn
- NZ$760.70m
- 52
- 83
- 47
- 67
Annual income statement for Ryman Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 456 | 509 | 571 | 690 | 761 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 428 | 502 | 591 | 853 | 988 |
| Operating Profit | 28.1 | 6.86 | -19.9 | -163 | -227 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 411 | 722 | 206 | -282 | -215 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 423 | 693 | 258 | -170 | -437 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 423 | 693 | 258 | -170 | -437 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 423 | 693 | 258 | -170 | -437 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.558 | 0.894 | 0.331 | -0.137 | -0.431 |
| Dividends per Share |